Our study “Infection-related mortality after hematopoietic stem cell transplantation in a high antimicrobial resistance setting” was published in European Journal of Clinical Microbiology & Infectious Diseases. Study findings reveal that for patients fighting for survival through stem cell transplants, the greatest threat isn’t the disease itself, but antibiotic-resistant “superbugs.” The research shows that 80% of deaths occurring within the first 100 days post-transplant are caused by infections, prompting an urgent call for “smart drugs” and stricter infection control in hospitals.
